Theseus Pharmaceuticals (THRX) Institutional Ownership → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free THRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Theseus Pharmaceuticals (NASDAQ:THRX)CurrentInstitutional OwnershipPercentage91.05%Number ofInstitutional Buyers(last 12 months)20TotalInstitutional Inflows(last 12 months)$23.68MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$1.30M Get THRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Theseus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data THRX Institutional Buying and Selling by Quarter Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report Theseus Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024 Frazier Life Sciences Management L.P.2,118,051$8.58M0.5%-5.8%4.789% 2/15/2024 Beryl Capital Management LLC288,887$1.17M0.6%N/A0.653% 2/14/2024 ADAR1 Capital Management LLC174,715$708K0.3%N/A0.395% 2/13/2024 Tower Research Capital LLC TRC 9,302$38K0.0%+62.2%0.021% 2/12/2024 MMCAP International Inc. SPC277,303$1.12M0.2%N/A0.627% 2/12/2024 Highbridge Capital Management LLC616,860$2.50M0.1%N/A1.395% Get the Latest News and Ratings for THRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theseus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/6/2024 AJOVista LLC9,520$39K0.0%N/A0.022% 2/2/2024 BML Capital Management LLC1,108,320$4.49M3.4%N/A2.506% 1/30/2024 BML Capital Management LLC1,108,317$4.49M3.5%N/A2.506% 1/30/2024 Strs Ohio46,300$187K0.0%+1,614.8%0.105% 1/19/2024 Denali Advisors LLC103,800$420K0.1%-18.8%0.235% 1/12/2024 SG Americas Securities LLC13,212$54K0.0%N/A0.030% 1/5/2024 Exchange Traded Concepts LLC48,510$196K0.0%+34.0%0.110% 11/15/2023 Laurion Capital Management LP171,157$460K0.0%-4.7%0.393% 11/15/2023 Affinity Asset Advisors LLC400,726$1.08M0.3%+66.8%0.919% 11/14/2023 Lynx1 Capital Management LP702,415$1.89M1.2%-7.2%1.611% 11/13/2023 Foresite Capital Management V LLC4,108,796$11.05M17.6%+14.6%9.424% 11/13/2023 Acadian Asset Management LLC259,470$696K0.0%N/A0.595% 11/8/2023 Forefront Analytics LLC17,672$48K0.0%N/A0.041% 10/27/2023 TD Asset Management Inc213,896$575K0.0%+100.0%0.491% 10/20/2023 Denali Advisors LLC127,900$344K0.1%+675.2%0.293% 10/18/2023 Exchange Traded Concepts LLC36,210$97K0.0%+144.8%0.083% 8/21/2023 Affinity Asset Advisors LLC240,244$2.24M0.8%+144.6%0.551% 8/15/2023 HighVista Strategies LLC136,719$1.28M0.6%N/A0.314% 8/14/2023 Driehaus Capital Management LLC232,693$2.17M0.0%+2.9%0.534% 8/8/2023 Candriam S.C.A.270,015$2.52M0.0%-16.6%0.620% 8/7/2023 Principal Financial Group Inc.10,679$100K0.0%N/A0.025% 8/2/2023 Bank of Montreal Can277,074$2.80M0.0%N/A0.636% 7/20/2023 Exchange Traded Concepts LLC14,791$138K0.0%N/A0.034% 7/18/2023 Denali Advisors LLC16,500$154K0.1%N/A0.038% 5/16/2023 Fairmount Funds Management LLC1,865,671$16.57M2.8%N/A4.281% 5/16/2023 Altium Capital Management LP112,614$1M0.6%N/A0.258% 5/16/2023 Boxer Capital LLC350,000$3.11M0.2%-15.7%0.803% 5/15/2023 Affinity Asset Advisors LLC98,221$872K0.3%N/A0.225% 5/10/2023Tekla Capital Management LLC75,000$666K0.0%-25.0%0.172% 5/3/2023 Jump Financial LLC15,859$141K0.0%N/A0.036% 2/14/2023 Boxer Capital LLC415,000$2.07M0.1%-53.5%1.072% 2/13/2023 Foresite Capital Management V LLC3,585,346$17.86M13.9%+7.5%9.262% 2/10/2023 Opaleye Management Inc.535,000$2.66M0.9%+142.5%1.382% 2/3/2023 Frazier Life Sciences Management L.P.1,398,194$6.96M0.4%N/A3.612% Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide11/15/2022Farallon Capital Management LLC223,149$1.29M0.0%-45.5%0.576% 11/14/2022 Forefront Analytics LLC13,065$74K0.0%N/A0.034% 8/16/2022 Woodline Partners LP211,684$1.17M0.0%-15.3%0.547% 8/16/2022 DAFNA Capital Management LLC81,899$453K0.1%+2.2%0.212% 8/15/2022 Opaleye Management Inc.32,300$179K0.1%N/A0.083% 8/12/2022 Ensign Peak Advisors Inc142,598$788K0.0%-43.0%0.368% 8/8/2022 Walleye Capital LLC31,719$175K0.0%N/A0.082% 8/4/2022 TD Asset Management Inc.106,948$591K0.0%+59.3%0.276% 5/10/2022 TD Asset Management Inc.67,133$774K0.0%+19.4%0.173% 5/5/2022 New York State Common Retirement Fund9,495$109K0.0%+475.1%0.025% 2/19/2022 Woodline Partners LP250,000$3.17M0.0%N/A0.646% 2/15/2022 Laurion Capital Management LP205,021$2.60M0.0%N/A0.530% 2/15/2022 Lynx1 Capital Management LP409,358$5.19M4.5%N/A1.058% 2/15/2022 Adage Capital Partners GP L.L.C.761,589$9.66M0.0%N/A1.968% 2/14/2022 Boxer Capital LLC892,057$11.31M0.4%N/A2.305% 2/14/2022 Nextech Invest AG611,310$7.75M1.8%N/A1.579% 2/14/2022 DAFNA Capital Management LLC97,500$1.24M0.3%N/A0.252% 2/14/2022 Omega Fund Management LLC711,479$9.02M1.3%N/A1.838% 2/11/2022Foresite Capital Opportunity Management V LLC468,820$5.95M4.0%N/A1.211% 2/11/2022 Ensign Peak Advisors Inc250,000$3.17M0.0%N/A0.646% 2/10/2022 TD Asset Management Inc.56,202$713K0.0%N/A0.145% 2/8/2022 Northern Trust Corp96,884$1.23M0.0%N/A0.250% 1/24/2022 Strs Ohio2,700$34K0.0%N/A0.007% (Data available from 1/1/2016 forward) THRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THRX shares? During the previous two years, 36 institutional investors and hedge funds held shares of Theseus Pharmaceuticals. The most heavily invested institutionals were Fairmount Funds Management LLC ($16.57M), Foresite Capital Management V LLC ($11.05M), Frazier Life Sciences Management L.P. ($8.58M), BML Capital Management LLC ($4.49M), Boxer Capital LLC ($3.11M), Bank of Montreal Can ($2.80M), and Opaleye Management Inc. ($2.66M).Learn more on THRX's institutional investors. What percentage of Theseus Pharmaceuticals stock is owned by institutional investors? 91.05% of Theseus Pharmaceuticals stock is owned by institutional investors. Learn more on THRX's institutional investor holdings. Which institutional investors have been buying Theseus Pharmaceuticals stock? Of the 28 institutional investors that purchased Theseus Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($2.22M), Fairmount Funds Management LLC ($1.87M), Frazier Life Sciences Management L.P. ($1.40M), Foresite Capital Management V LLC ($773.45K), Highbridge Capital Management LLC ($616.86K), Affinity Asset Advisors LLC ($400.73K), and Opaleye Management Inc. ($346.65K). How much institutional buying is happening at Theseus Pharmaceuticals? Institutional investors have bought a total of 9,635,304 shares in the last 24 months. This purchase volume represents approximately $52.69M in transactions. Which Theseus Pharmaceuticals major shareholders have been selling company stock? Of the 10 institutional investors that sold Theseus Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Boxer Capital LLC ($542.06K), Farallon Capital Management LLC ($186.57K), Frazier Life Sciences Management L.P. ($130.14K), Ensign Peak Advisors Inc ($107.40K), Lynx1 Capital Management LP ($54.59K), Candriam S.C.A. ($53.80K), and Woodline Partners LP ($38.32K). How much institutional selling is happening at Theseus Pharmaceuticals? Institutional investors have sold a total of 1,170,443 shares in the last 24 months. This volume of shares sold represents approximately $6.36M in transactions. Related Companies: OM Major Shareholders CGEN Major Shareholders HITI Major Shareholders GALT Major Shareholders GLSI Major Shareholders DRTS Major Shareholders GNFT Major Shareholders ADVM Major Shareholders LFCR Major Shareholders OBIO Major Shareholders This page (NASDAQ:THRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theseus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.